SDIX Key Stats
| Income Statement | |
| Revenue TTM | 18.58M |
| Revenue Quarterly YoY Growth | -8.56% |
| EPS Diluted TTM | 0.2095 |
| EPS Diluted Quarterly YoY Growth | 366.1% |
| Net Income TTM | 4.343M |
| Profitability | |
| Gross Profit Margin Quarterly | 46.00% |
| Profit Margin Quarterly | |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 21.33M |
| Enterprise Value | 3.421M |
| PE Ratio TTM | 4.820 |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 0.8494 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.0095 |
| Free Cash Flow | -0.92M |
| Return on Equity | 22.03% |
SDIX News
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 10-Q, Quarterly Report May 15
- Egalet Appoints Stan Musial as CFO PR Newswire May 8
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 10-K, Annual Report Apr 15
- China Biotech In Review: Lilly Invests $100 Million In China Animal Healthcare Apr 14
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 8-K, Entry into a Material Definiti... Apr 10
- OriGene to Acquire SDIX's Life Science Business Assets PR Newswire Apr 8
- Strategic Diagnostics (SDIX) Will Resume Trading at 9:45am ET Street Insider Apr 8
- SDIX (SDIX) to Sell Life Science Assets in $16M Deal Street Insider Apr 8
- SDIX Sells Life Science Assets to OriGene Technologies, Inc. for $16 Million Business Wire Apr 8
- SDIX trading halted, pending news Apr 8
SDIX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Strategic Diagnostics is down 39.16% over the last year vs S&P 500 Total Return up 29.62%, EntreMed down 8.50%, and ARCA biopharma down 7.58%.
SDIX Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these SDIX related companies
Pro Ratings for SDIX
Pro Report PDF for SDIX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download SDIX Pro Report PDF
Pro Strategies Featuring SDIX
Did Strategic Diagnostics make it into our Pro Portfolio Strategies?
SDIX Profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Other SDIX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SDIX | 1.01 | -0.04 | -3.81% | 21.33M |
